Trial Profile
Effect of Dexmedetomidine on Heart-rate Corrected QT Interval Prolongation During Robotic-assisted Laparoscopic Radical Prostatectomy -Randomized Blind Clinical Trial-
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Feb 2016
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- 28 Jan 2016 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
- 08 Sep 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.
- 02 Sep 2015 New trial record